Suzuki-Chiba, Hiroe http://orcid.org/0000-0002-4288-177X
Konishi, Takaaki http://orcid.org/0000-0002-9538-4419
Aso, Shotaro http://orcid.org/0000-0002-7804-2433
Makito, Kanako http://orcid.org/0000-0003-4165-7917
Matsui, Hiroki http://orcid.org/0000-0003-0004-4743
Jo, Taisuke http://orcid.org/0000-0002-8503-022X
Fushimi, Kiyohide http://orcid.org/0000-0002-1894-0290
Yasunaga, Hideo http://orcid.org/0000-0002-6017-469X
Funding for this research was provided by:
Ministry of Health, Labour and Welfare (23AA2003, 22AA2003, 22AA2003)
The University of Tokyo
Article History
Received: 19 November 2023
Accepted: 7 August 2024
First Online: 18 August 2024
Declarations
:
: Dr. Konishi received grants from Pfizer Co. Ltd., the Japan Kampo Medicines Manufacturers’ Association, and Kanzawa Medical Research Foundation outside the submitted work. The authors declare no conflict of interest.
: Authorization was obtained from the Institutional Review Board of the University of Tokyo (approval number 3501-5; May 19, 2021). This study has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: The requirement for informed consent was waived due to the use of anonymous data.
: The requirement for consent to publish was waived due to the use of anonymous data.